Vinod Kumar Gurjar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vinod Kumar Gurjar has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Ankur Vaidya
Pharmacy College Saifai, Uttar Pradesh University of Medical Sciences (UPUMS), Saifai, Etawah, India
1 shared publication Banty Kumar
Department of Pharmaceutical Chemistry Faculty of Pharmacy Uttar Pradesh University of Medical Sciences Etawah Uttar Pradesh India
1 shared publication- Dilipkumar Pal
Guru Ghasidas Vishwavidyalaya (A Central University)
1 shared publication Dodiya Raj Mukeshbhai
1 shared publicationKushwaha Raju
1 shared publication- Neeraj Upmanyu
Sagar Institute of Research and Technology‐Pharmacy Sanjeev Agrawal Global Educational (SAGE) University Bhopal Madhya Pradesh India
1 shared publication
Latest Publications
- Open Access
- 4 August 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (30) , e74007
Recent Updates on Novel Quinazoline‐Hybrid Molecules Possessing EGFR‐Mediated Anticancer Activity
As the first member of the receptor tyrosine kinase family, epidermal growth factor (EGFR) has been linked to human cancers through numerous lines of evidence. Research on EGFR has also led to the development of several key theories regarding cancer progression. Through a vast array of paracrine loops, each of which regulates a crucial stage in the metastasis cascade, EGFR not only maintains cell proliferation but also confers resistance to anti‐cancer cytotoxic treatments. To identify EGFR tyrosine kinase inhibitors (TKIs), simulation studies have been used to produce several small molecules, especially those containing quinazolines. The design process also evaluated the emergence of resistance problems and epigenetic changes, which eventually reduced drug efficacy and made it clear that more study in this field was required. The genetic changes taking place in the EGFR tyrosine kinase domain have been thoroughly studied in recent decades. These changes have made it possible to create highly effective inhibitors. The structure–activity relationship (SAR) and cytotoxic activity of several quinazoline derivatives with demonstrated EGFR‐inhibitory antiproliferative activity are highlighted in this review. In the present paper, we report the EGFR‐mediated anticancer potential of quinazoline derivatives discovered after 2020.
- 4 August 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (30) , e74007
Open AccessRecent Updates on Novel Quinazoline‐Hybrid Molecules Possessing EGFR‐Mediated Anticancer Activity
As the first member of the receptor tyrosine kinase family, epidermal growth factor (EGFR) has been linked to human cancers through numerous lines of evidence. Research on EGFR has also led to the development of several key theories regarding cancer progression. Through a vast array of paracrine loops, each of which regulates a crucial stage in the metastasis cascade, EGFR not only maintains cell proliferation but also confers resistance to anti‐cancer cytotoxic treatments. To identify EGFR tyrosine kinase inhibitors (TKIs), simulation studies have been used to produce several small molecules, especially those containing quinazolines. The design process also evaluated the emergence of resistance problems and epigenetic changes, which eventually reduced drug efficacy and made it clear that more study in this field was required. The genetic changes taking place in the EGFR tyrosine kinase domain have been thoroughly studied in recent decades. These changes have made it possible to create highly effective inhibitors. The structure–activity relationship (SAR) and cytotoxic activity of several quinazoline derivatives with demonstrated EGFR‐inhibitory antiproliferative activity are highlighted in this review. In the present paper, we report the EGFR‐mediated anticancer potential of quinazoline derivatives discovered after 2020.
- 1 November 2023
- Published by Springer Nature
- p. 97-195
Classification of Medicinal Plants Showing Anti-Viral Activity, Classified by Family and Viral Infection Types
- 1 November 2023
- Published by Springer Nature
- p. 97-195
Classification of Medicinal Plants Showing Anti-Viral Activity, Classified by Family and Viral Infection Types
- Open Access
- 31 August 2023
- Published by Medic Scientific in Journal of Medical pharmaceutical and allied sciences
- Vol. 12 (4) , 6001-6011
Design synthesis in-silico study and biological evaluation of quinoline derivatives as potential antibacterial agents
The purpose of this article is to synthesize some novel quinoline-3-Carboxylic acid derivatives, analyze them, and assess their antibacterial potential. With the help of elemental analysis, IR, NMR, and mass spectral data, the synthesized derivatives were identified. Derivatives' antibacterial activity was determined using the cup and plate diffusion method. At doses of 50 μg/ml and 100 μg/ml, the substance demonstrated substantial antibacterial potential against the tested strains. To predict the pharmacokinetic properties (ADME) of these derivatives, in-silico investigations were also carried out. For the current study, the in silico Swiss ADME-assisted results were shown to be suitable for the derivation and synthesis of efficient antibacterial drugs.
- 31 August 2023
- Published by Medic Scientific in Journal of Medical pharmaceutical and allied sciences
- Vol. 12 (4) , 6001-6011
Open AccessDesign synthesis in-silico study and biological evaluation of quinoline derivatives as potential antibacterial agents
The purpose of this article is to synthesize some novel quinoline-3-Carboxylic acid derivatives, analyze them, and assess their antibacterial potential. With the help of elemental analysis, IR, NMR, and mass spectral data, the synthesized derivatives were identified. Derivatives' antibacterial activity was determined using the cup and plate diffusion method. At doses of 50 μg/ml and 100 μg/ml, the substance demonstrated substantial antibacterial potential against the tested strains. To predict the pharmacokinetic properties (ADME) of these derivatives, in-silico investigations were also carried out. For the current study, the in silico Swiss ADME-assisted results were shown to be suitable for the derivation and synthesis of efficient antibacterial drugs.
- Open Access
- 30 April 2023
- Published by Oriental Scientific Publishing Company in Oriental Journal of Chemistry
- Vol. 39 (2) , 320-334
Design, Synthesis, in Silico Study and Biological Evaluation of 1,8-Naphthyridine Derivatives as Potential Antibacterial Agents
Oriental Journal of Chemistry is a peer reviewed quarterly research journal of pure and applied chemistry. It publishes standard research papers in almost all thrust areas of current chemistry of academic and commercial importance. It provides a platform for rapid publication of quality research papers, reviews and chemistry letters. Oriental Journal of Chemistry is abstracted and indexed in almost all reputed National and International agencies.
- 30 April 2023
- Published by Oriental Scientific Publishing Company in Oriental Journal of Chemistry
- Vol. 39 (2) , 320-334
Open AccessDesign, Synthesis, in Silico Study and Biological Evaluation of 1,8-Naphthyridine Derivatives as Potential Antibacterial Agents
Oriental Journal of Chemistry is a peer reviewed quarterly research journal of pure and applied chemistry. It publishes standard research papers in almost all thrust areas of current chemistry of academic and commercial importance. It provides a platform for rapid publication of quality research papers, reviews and chemistry letters. Oriental Journal of Chemistry is abstracted and indexed in almost all reputed National and International agencies.